Artificial Intelligence (AI)-Powered Pathology Analysis System Market Report 2026

Artificial Intelligence (AI)-Powered Pathology Analysis System Market Overview

• Artificial Intelligence (AI)-Powered Pathology Analysis System market size has reached to $66.06 billion in 2025 • Expected to grow to $153.02 billion in 2030 at a compound annual growth rate (CAGR) of 18.3% • Growth Driver: Increasing Cancer Incidence Fueling The Growth Of The Market Due To Rising Need For Early Detection, Accurate Diagnosis, And Efficient Tissue Sample Analysis • Market Trend: Advanced AI-Driven Cancer Detection And Diagnostic Support In Digital Pathology • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Artificial Intelligence (AI)-Powered Pathology Analysis System Market?

Artificial intelligence (AI)-powered pathology analysis system is a technology-enabled solution that leverages artificial intelligence and machine learning algorithms to analyze medical images, histopathology slides, and diagnostic data for accurate and efficient disease detection. Its primary goal is to enhance diagnostic accuracy, reduce turnaround time, minimize human error, and support pathologists in clinical decision-making. The main components of artificial intelligence (AI)-powered pathology analysis system include software, hardware, and services. Software refers to AI-driven platforms that analyze pathology images and clinical data to assist in disease detection, diagnosis, and workflow optimization. These systems utilize technologies including machine learning, computer vision, and natural language processing, and are utilized by end users including hospitals, diagnostic laboratories, research institutes, and pharmaceutical and biotech companies.

What Is The Artificial Intelligence (AI)-Powered Pathology Analysis System Market Growth Forecast?

The artificial intelligence (AI)-powered pathology analysis system market size is expected to see rapid growth in the next few years. It will grow to $153.02 billion in 2030 at a compound annual growth rate (CAGR) of 18.3%. The growth in the forecast period can be attributed to advancement in ai and deep learning algorithms for medical image analysis, expansion of precision medicine and genomics-driven diagnostics, increasing adoption of cloud-based healthcare data ecosystems, growth in telepathology and remote diagnostic services, rising investment in healthcare digital transformation and automation. Major trends in the forecast period include increasing adoption of ai-powered digital pathology platforms for high-accuracy disease detection, growing use of cloud-based pathology data management systems for remote diagnostics, rising integration of deep learning models in histopathology image interpretation, expansion of automated slide scanning and digital workflow solutions in diagnostic laboratories, increasing demand for ai-assisted clinical decision support systems in oncology and disease screening.

Global Artificial Intelligence (AI)-Powered Pathology Analysis System Market Segmentation

1) By Components: Software; Hardware; Services 2) By Technology: Machine Learning; Computer Vision; Natural Language Processing 3) By End User: Hospitals; Diagnostic Laboratories; Research Institutes; Pharmaceutical And Biotech Companies Subsegments: 1) By Software: Image Analysis Software; Workflow Management Software; Data Management Software; Reporting And Visualization Software; Quality Control Software 2) By Hardware: Slide Scanners; Digital Microscopes; Servers And Storage Systems; High Performance Computing Systems; Imaging Devices 3) By Services: Installation And Integration Services; Maintenance And Support Services; Consulting Services; Training And Education Services; Data Analysis And Interpretation Services

What Is The Driver Of The Artificial Intelligence (AI)-Powered Pathology Analysis System Market?

The increasing cancer incidence is expected to propel the growth of the artificial intelligence (AI)-powered pathology analysis system market going forward. Cancer is a disease characterized by the uncontrolled multiplication of abnormal cells that can invade and spread to other parts of the body, arising in various tissues and organs and classified based on the cell or tissue type from which it originates. Cancer cases are increasing due to rising life expectancy, as the risk of developing cancer grows with age. AI-powered pathology analysis systems are used in cancer incidence by automatically analyzing biopsy and tissue samples to detect, classify, and quantify cancerous cells, enabling faster and more accurate diagnosis and supporting early detection of cancer cases. For instance, in August 2024, according to the Macmillan Cancer Support, a UK-based organization, more than 3 million people in the UK were living with cancer in 2024, this figure was projected to increase to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Therefore, the increasing cancer incidence is driving the growth of the artificial intelligence (AI)-powered pathology analysis system industry.

Key Players In The Global Artificial Intelligence (AI)-Powered Pathology Analysis System Market

Major companies operating in the artificial intelligence (AI)-powered pathology analysis system market are F. Hoffmann-La Roche Ltd.; Danaher Corporation; Koninklijke Philips N.V.; Hologic Inc.; Tempus AI Inc.; Owkin Inc.; OptraSCAN Inc.; Proscia Inc.; Tribun Health; 3DHISTECH Ltd.; Visiopharm A/S; Indica Labs Inc.; Ibex Medical Analytics Ltd.; Mindpeak GmbH; Aiosyn; DeepBio Inc.; AIRA Matrix Pvt. Ltd.; Aiforia Technologies Plc.; Lunit Inc.; Google Cloud

Global Artificial Intelligence (AI)-Powered Pathology Analysis System Market Trends and Insights

Major companies operating in the artificial intelligence (AI)-powered pathology analysis system market are focusing on developing advanced solutions, such as AI-driven cancer detection and diagnostic support platforms to enhance pathology workflow efficiency, improve diagnostic accuracy, accelerate clinical decision-making, and address the growing shortage of pathologists in healthcare systems. AI-driven cancer detection and diagnostic support platforms are software systems that use artificial intelligence to analyze medical data and images, helping healthcare professionals identify potential cancerous abnormalities and make more informed diagnostic decisions. For instance, in April 2025, Paige.AI Inc., a US-based healthcare technology company, has received U.S. Food and Drug Administration (FDA) Breakthrough Device Designation for its AI application Paige PanCancer Detect, which is designed to assist pathologists in identifying cancerous regions across multiple tissue and organ types. The system uses advanced artificial intelligence to detect both common and rare cancer variants, helping improve diagnostic accuracy and reduce turnaround time in pathology workflows. It aims to address the increasing global shortage of pathologists by streamlining case screening and supporting faster clinical decision-making. This recognition highlights the growing role of AI in precision oncology and strengthens Paige’s position in developing regulatory-approved digital pathology solutions for improved cancer detection and patient care.

What Are Latest Mergers And Acquisitions In The Artificial Intelligence (AI)-Powered Pathology Analysis System Market?

In May 2026, Grundium Oy, a Finland-based medical technology company, acquired Visiopharm A/S for an undisclosed amount. As a result of the acquisition, Grundium advanced its strategy of building a broader digital and computational pathology platform by integrating Visiopharm’s AI-driven precision pathology software with its cutting-edge imaging technology. The combined capabilities created a comprehensive end-to-end pathology solution for diagnostic laboratories, biopharmaceutical development, and research applications. Visiopharm A/S is a Denmark-based company specializing in AI-powered pathology analysis software and related services.

Regional Outlook

North America was the largest region in the artificial intelligence (AI)-powered pathology analysis system market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Artificial Intelligence (AI)-Powered Pathology Analysis System Market?

The artificial intelligence (AI)-powered pathology analysis system market consists of revenues earned by entities by providing services such as automated image analysis, digital pathology integration, AI-based diagnostic support, pattern recognition, predictive analytics, and clinical decision support systems. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI)-powered pathology analysis system market also includes sales of whole-slide scanners, fluorescence slide scanners, automated microscopy systems, digital pathology workstations, and medical-grade display monitors. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Artificial Intelligence (AI)-Powered Pathology Analysis System Market Report 2026?

The artificial intelligence (ai)-powered pathology analysis system market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (ai)-powered pathology analysis system industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.